2
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
1
Conditions
Urinary Bladder Neoplasms
2
Hyperthermia
2
Breast Neoplasms
2
Uveal Melanoma
1
Ureteral Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Retinoblastoma
1
Prostatic Neoplasms
1
Oropharyngeal Neoplasms
1
Neoplasm Metastasis
1
Laryngeal Neoplasms
1
Hypopharyngeal Neoplasms
1
Hematologic Neoplasms
1
Head and Neck Neoplasms
1
Carcinoma, Hepatocellular
1
Interventions
Cisplatin
35
Radiotherapy
21
Magnetic Resonance Spectroscopy
19
Cetuximab
17
Specimen Handling
15
pembrolizumab
13
Carboplatin
13
Radiotherapy, Intensity-Modulated
12
Fluorouracil
12
Docetaxel
12
1,2-diaminocyclohexaneplatinum II citrate
10
Radiation
9
Platinum
9
Surgical Procedures, Operative
8
Paclitaxel
8
Drug Therapy
7
Biopsy
7
Taxes
5
Surveys and Questionnaires
5
toripalimab
4
X-Rays
4
Standard of Care
4
Fluorodeoxyglucose F18
4
Celecoxib
4
(225)Ac-DOTA-c(RGDyK)
4
cemiplimab
3
Nutritional Status
3
Laser Therapy
3
Interviews as Topic
3
Immunohistochemistry
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Laryngeal Neoplasms
×
Hyperthermia, Induced
×
Clear all
NCT06761937
2025-07-25
TANCA-I
Erasmus Medical Center
Phase 1
Recruiting
30 enrolled